Cupid Promoter Aditya Kumar Halwasiya Acquires 4.8 Lakh Shares in Open Market Transaction

Cupid experienced notable promoter activity with Aditya Kumar Halwasiya acquiring a substantial stake through open market purchases. The transaction demonstrates active participation by the company's leadership in the equity markets and was conducted in compliance with SEBI regulations on March 30, 2026.

Regulatory Disclosure Details

The company received formal disclosure from Mr. Aditya Kumar Halwasiya under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The disclosure was submitted to both BSE Limited and National Stock Exchange of India Limited from his registered address at Belair, Flat No. 18A/9A, Alipore Park Place, Alipore, Kolkata, West Bengal.

Parameter:	Details
Promoter Name:	Aditya Kumar Halwasiya
Shares Acquired:	4.80 lakh
Transaction Date:	March 30, 2026
Transaction Type:	Open Market Purchase
Face Value:	Re. 1/- each
Transaction Mode:	Market Purchase

Shareholding Pattern Changes

The acquisition resulted in changes to the promoter's shareholding in the company. The detailed shareholding information shows the impact on overall promoter group holdings and diluted share capital calculations.

Shareholding Details:	Before Acquisition	After Acquisition
Aditya Kumar Halwasiya Shares:	44,24,45,475	44,29,25,475
Percentage Holding:	32.90%	32.94%
Total Promoter Group:	61,66,44,725	61,71,24,725
Combined Percentage:	45.85%	45.89%
Diluted Capital Percentage:	45.77%	45.81%

Company Capital Structure

The regulatory filing provides comprehensive details about Cupid Limited's capital structure and shareholding framework. The company maintains its equity share capital structure unchanged despite the promoter acquisition.

Capital Structure:	Details
Equity Share Capital:	Rs. 134,46,60,700
Total Equity Shares:	134,46,60,700 shares
Diluted Share Capital:	Rs. 134,70,00,000
Diluted Equity Shares:	134,70,00,000 shares
Face Value per Share:	Re. 1/-

Market Implications

Promoter purchases in the open market are typically interpreted as positive signals by market participants. Such transactions often indicate management confidence in company fundamentals and belief in future growth prospects. The acquisition represents a strategic positioning by the promoter, reflecting active engagement with the company's equity structure.

Regulatory Compliance

The transaction was conducted through open market mechanisms on March 30, 2026, ensuring transparency and regulatory compliance. The disclosure includes detailed calculations of diluted share capital, accounting for outstanding convertible securities and warrants. Company Secretary and Compliance Officer facilitated the disclosure process, ensuring all stakeholders were informed of the ownership changes in accordance with SEBI requirements.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.17%	+21.12%	+42.12%	+125.63%	+663.88%	+913.71%

Cupid Limited has announced the reconstitution of its Audit Committee through a Board resolution passed by circulation on March 30, 2026. The healthcare products manufacturer communicated this corporate governance update to both BSE and NSE under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Committee Composition

The reconstituted Audit Committee comprises three members, all holding Non-Executive & Independent Director positions. The new structure ensures compliance with corporate governance norms for listed companies.

Position	Name	Category
Chairperson	Mrs. Rajni Mishra	Non-Executive & Independent Director
Member	Mr. Thallapaka Venkateswara Rao	Non-Executive & Independent Director
Member	Mr. Bontha Prasada Rao	Non-Executive & Independent Director

Regulatory Compliance

The company filed the mandatory disclosure with stock exchanges to inform stakeholders about the committee changes. Company Secretary and Compliance Officer Saurabh V. Karmase digitally signed the regulatory filing on March 30, 2026.

Company Background

Cupid Limited operates as a manufacturer and exporter of male condoms, female condoms, water-based lubricants, and In Vitro Diagnostics (IVD) kits. The company is headquartered at A-68, M.I.D.C. (Malegaon), Sinnar, Nashik, Maharashtra, and trades on BSE under scrip code 530843 and NSE under scrip code CUPID.

The reconstitution reflects the company's commitment to maintaining robust corporate governance practices through independent oversight of its audit functions.